This inventor holds 1 USPTO granted patent. Top assignee: Nippon Zoki Pharmaceutical Co., Ltd.. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Innovations in Osteoporosis Treatment by Shinichiro Aonuma
Introduction
Shinichiro Aonuma is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of osteoporosis. His innovative approach combines the use of estrogen and thyroid hormone to enhance bone density.
Latest Patents
Aonuma holds a patent for a pharmaceutical composition aimed at treating osteoporosis. This composition utilizes an estrogen and a thyroid hormone as effective ingredients. By combining these two components, the treatment demonstrates superior efficacy in increasing bone mass compared to administering estrogen alone. He has 1 patent to his name.
Career Highlights
Aonuma is associated with Nippon Zoki Pharmaceutical Co., Ltd., where he continues to work on advancing pharmaceutical solutions. His research focuses on improving treatment options for osteoporosis, which is a significant health concern for many individuals.
Collaborations
Some of his notable coworkers include Tomoshi Miura and Hiroyuki Ohara, who contribute to the innovative research environment at Nippon Zoki Pharmaceutical Co., Ltd.
Conclusion
Shinichiro Aonuma's work in developing a pharmaceutical composition for osteoporosis treatment showcases his commitment to enhancing patient care through innovation. His contributions are vital in the ongoing battle against osteoporosis, providing hope for improved health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile